Table 3.

Net budgetary impact of ferric citrate vs. standard of care; base-case model

	Net budgetary impact of ferric citrate vs. SOC (US$/year per 100 patients treated)
	Mean (SEM)	Median [p25; p75]	p valuea
Overall	+213,223 (14,111)	+213,018 [203,743; 222,109]	<0.001
Component: missed treatment	+12,766 (4276)	+12,474 [9622; 15,748]	<0.001
Component: ESA	+194,452 (13,683)	+194,652 [185,618; 203,423]	<0.001
Component: IV iron	+5775 (948)	+5806 [5171; 5807]	<0.001

ESA erythropoiesis-stimulating agent, IV intravenous, SEM standard error of mean, SOC standard of care

^a p value for comparison of mean, ferric citrate vs. SOC